VIDEO: Pegcetacoplan slows geographic atrophy progression at 3 years
Click Here to Manage Email Alerts
In this Healio Video Perspective from Angiogenesis, Exudation, and Degeneration 2024, Roger A. Goldberg, MD, MBA, discusses 3-year data investigating pegcetacoplan for the treatment of geographic atrophy.
“It does slow GA progression anatomically,” he said. “Those prespecified functional endpoints didn’t hit in the clinical trials, but we’ve got a lot of, I think, really high-quality post hoc analyses that do show slowing of vision loss when the GA is more than 250 µm away, delaying of progression to legal blindness, protecting the visual field around the areas of atrophy and protecting the visual field centrally.”
Collapse
Goldberg RA. Functional benefits with pegcetacoplan. Presented at: Angiogenesis, Exudation, and Degeneration 2024; Feb. 3, 2024 (virtual meeting).
Read more about
Click Here to Manage Email Alerts